vTv Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-20.25	-19.16	-12.99	-8.5	-17.91	Upgrade
Depreciation & Amortization	0.09	0.09	0.09	0.09	0.04	Upgrade
Share-Based Compensation	1.58	1.27	2.36	1.01	1.52	Upgrade
Other Operating Activities	-0.5	1.78	-8.77	-10.6	-11.53	Upgrade
Operating Cash Flow	-19.08	-16.02	-19.31	-18	-23.02	Upgrade
Capital Expenditures	0	-0.02	0	0	0.24	Upgrade
Change in Investments	4.4	0	0	0	0	Upgrade
Investing Cash Flow	4.4	-0.02	0	0	0.24	Upgrade
Share Issuance / Repurchase	12.03	14.79	26.8	24.43	32.94	Upgrade
Debt Issued / Paid	-0.03	-0.03	0.17	-4.96	-10.07	Upgrade
Financing Cash Flow	12	14.75	26.98	19.47	22.87	Upgrade
Net Cash Flow	-2.68	-1.29	7.67	1.47	0.09	Upgrade
Free Cash Flow	-19.08	-16.04	-19.31	-18	-22.78	Upgrade
Free Cash Flow Margin	-	-795.00%	-482.10%	-280.64%	-824.02%	Upgrade
Free Cash Flow Per Share	-7.30	-6.14	-8.58	-9.74	-15.21	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).